Neoadjuvant immunotherapy: new horizon for lymph node preservation.

A study by Rahim et al. explores the use of neoadjuvant immunotherapy in cancer treatment, specifically focusing on the preservation of lymph nodes. The study suggests that preserving lymph node integrity can enhance the efficacy of immunotherapy by activating antitumor T cells. The researchers found that immunotherapy primarily activates lymph nodes rather than intratumoral T cells, highlighting the importance of lymph node preservation. The study advocates for the use of immunotherapy as a neoadjuvant intervention and emphasizes the need for further research in this area. [Extracted from the article]